This inventor holds 1 USPTO granted patent. Top assignees: University of Miami, University System of Maryland. Active years: 2019.
Company Filing History:
1 out of 391 
1 out of 2,025 
Years Active: 2019
Title: Alex Mackerell, Jr: Innovator in Cancer Treatment
Introduction
Alex Mackerell, Jr. is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the Notch transcriptional activation complex, which plays a crucial role in various diseases, including cancer.
Latest Patents
Mackerell holds a patent for "Inhibitors of the Notch transcriptional activation complex and methods for use of the same." This patent discloses inhibitors that can be utilized in treating or preventing diseases, particularly cancer. The inhibitors described can include compounds of Formula (I) and pharmaceutically acceptable salts thereof, with specific substituents as outlined in the patent documentation.
Career Highlights
Throughout his career, Alex Mackerell, Jr. has worked with esteemed institutions such as the University System of Maryland and the University of Miami. His research has been pivotal in advancing the understanding of the Notch signaling pathway and its implications in cancer therapy.
Collaborations
Mackerell has collaborated with notable colleagues, including Mark Spyvee and Anthony J Capobianco. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.
Conclusion
Alex Mackerell, Jr. is a distinguished inventor whose work in developing inhibitors for the Notch transcriptional activation complex has the potential to transform cancer treatment. His contributions to research and collaboration with leading institutions underscore his commitment to advancing medical science.